FMS European Long-Term Study

NCT00757731 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

490

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia Syndrome

Interventions

DRUG: milnacipran
DRUG: Placebo

Sponsor

Pierre Fabre Medicament